2024

June 17 (In Spanish) César de la Fuente is interviewed on the radio show “Herrera en la Cope” on Cope.
June 17 (In Spanish) César de la Fuente is interviewed on the radio show “La Rosa de los Vientos” on Onda Cero.
June 16 (In Spanish) Elciudadano.com publishes an article on AI resurrecting molecules from extinct creatures to create antibiotics.
June 15 (In Spanish) Noticias & Protagonistas writes an article on the use of AI to revive molecules and create antibiotics.
June 15 (In Spanish) ContraRéplica covers the reviving of extinct molecules with AI to create antibiotics.
June 15 (In Spanish) Alumni León publishes an article on César de la Fuente’s innovative research.
June 15  The Telegraph writes an article on antibiotics created from extinct species to fight infections.
June 14 El imparcial publishes an article on the identification of nearly 1M antibiotics in nature thanks to AI.
June 14 Smart Factory Magazine publishes a piece on the use of AI to combat antibiotic resistance.
June 14 (In Spanish) Revista Flow publishes an article on AI reviving mammoth molecules.
June 14  Penn Bioengineering Blog publishes a piece on looking to AI to solve antibiotic resistance.
June 14  (In Spanish) Merca2 writes an article about the use of AI to generate more resistant antibiotics.
June 13 (In Spanish) Sputnik publihes an article about César de la Fuente discovering almost limitless sources of new antibiotics, even in extinct organisms.
June 13  (In Spanish) El Diario. writes an article on the discovery of new antibiotic molecules in extinct organisms thanks to AI.
June 13 (In Spanish) El Confidencial Digital publishes a piece referring to César de la Fuente’s discovery of potential new antibiotics in extint organisms.
June 12 (In Spanish) El Nacional writes a piece on AI finding nearly a million possible natural antibiotics.
June 12 News Medical Lifes Sciences writes an article on deep learning reviving ancient peptides to battle antibiotic resistance.
June 12 Swarajya writes an article on AI to the rescue in fight against antibiotic resistance.
June 12 PHYS.ORG publishes an article on researchers looking to AI to solve antibiotic resistance.
June 12 (In Spanish) Muy interesante writes an article on César de la Fuente’s research to revive molecules from mammoths to create new antibiotics.
June 12 (In Japanese) Nipponese news publishes an article on César de la Fuente an his team reviving mammoth molecules to create antibiotics.
June 12 (In Spanish) El Mundo writes an article on César de la Fuente looking for new antibiotics by ‘resurrecting’ molecules from extinct organisms.
June 12 (In Spanish) News ES.Euro publishes an article on César de la Fuente revolutionizing the search for new antibiotics.
June 12 (In Spanish) Crónica El Español writes an article mentioning the finding of potential antibiotics thanks to a new AI model.
June 12 (In Spanish) La Opinión A Coruña publishes an article on De la Fuente and his team discovering with AI thousands of antibiotics in extinct organisms.
June 12 (In Spanish) Huffington Post writes an article on César de la Fuente revolutionizing the search for new antibiotics.
June 11  Elblog.pl covers the discovery of trove of potential antibiotics thanks to AI.
June 11 (In Spanish) Zócalo writes an article on AI reviving molecules from extinct organisms to create antibiotics.
June 11 (In Spanish) El Tiempo publishes an article on how AI was used to resurrect molecules from creatures of the past to create antibiotics.
June 11 (In Spanish) yahoo! finanzas publishes an article on the discovery of potencial antibiotics by reviving molecules from extinct organisms.
June 11 (In Spanish) 20 minutos publishes an article about the resurrection of extinct molecules to create antibiotics.
June 11  (In Spanish) WIRED writes an article on an AI uses mammoth molecules to create more effective antibiotics.
June 11 D1SoftballNews publishes an article on César de la Fuente leading a study that uses AI to discover almost a million new antibiotics in just a few hours.
June 11  (In Spanish) Vanguardia MX covers the resurrection of molecules from extinct organisms to create antibiotics.
June 11 Penn Today publishes an article on looking to AI to solve antibiotic resistance.
June 11 (In Spanish) Diario de Morelos writes an article about AI reviving molecules from extinct animals to combat antibiotic resistance.
June 11 (In Spanish) Doce TV publishes an article on AI reviving molecules from creatures of the past to create antibiotics.
June 11 (In Spanish) Análisis Urbano covers the discovery of potential antibiotics thanks to AI reviving molecules of creatures from the past.
June 11 (In French) Nouvelles du Monde publishes an article on César de la Fuente resurrecting molecules to create antibiotics.
June 11 (In Spanish) FORBES México writes a piece on AI reviving molecules from extinct species to advance in the creation of antibiotics.
June 11 (In Spanish) Diario de la Mancha writes an article about mammoth molecules as a new hope against infections.
June 11 (In Spanish) Artículos Clave publishes an article about reviving molecules from the past with the help of AI.
June 11 (In Spanish) Diario de la Mancha writes an article about mammoth molecules as a new hope against infections.
June 11 (In Spanish) Diario Médico publishes an article on new antibiotic candidates found through AI in extinct organisms.
June 11 (In Spanish) El Debate Galicia publishes an article on César de la Fuente’s discovery of nearly a million new antibiotic molecules in a few hours with AI.
June 11 (In Spanish) La Jornada Maya covers the discovery of potentian antibiotics in extinct organisms.
June 11 (In Spanish) El Sol de México writes a piece on the resurrection of molecules from extinct organisms to create new antibiotics.
June 11 (In Spanish) MSN publishes a piece on AI resurrecting molecules of creatures from the past to create antibiotics.
June 11  (In Spanish) Columna Digital covers the discovery of potential antimicrobials from extinct organisms.
June 11 (In Spanish) ABC publishes an article on César de la Fuente reviving mammoth molecules to create antibiotics.
June 11 (In Spanish) López Dóriga Digital writes an article on AI resurrecting molecules from creatures of the past to create antibiotics.
June 11 (In Spanish) Infobae publishes a piece on AI reviving molecules from creatures of the past to create antibiotics.
June 11 (In Spanish) TVE interviews César de la Fuente on molecular de-extinction research and the use of AI for antibiotic discovery.
June 11 (In Spanish) GCiencia writes an article on César de la Fuente’s research resuscitating molecules from mammoths and other extinct animals to create antibiotics.
June 11 (In Spanish) MUNDIARIO publishes an article on the discovery of potential antimicrobial molecules in extinct mammoths as a hope against future infections.
June 11 (In Spanish) Radio Catalunya covers the discovery of potential antibiotics extracted from the remains of extinct animals.
June 11 (In Spanish) Notas de prensa writes an article on AI reviving molecules to produce antibiotics.
June 11 (In Spanish) NewS ES EURO publishes a piece on AI reviving molecules to create antibiotics.
June 11 (In Spanish) La Voz de Galicia writes a piece about César de la Fuente reviving mammoth molecules to create new antibiotics.
June 11 (In Spanish) La Vanguardia publishes an article on wew antibiotics found in extinct animals such as the mammoth thanks to AI.
June 11 (In Spanish) Faro de Vigo covers the discovery of thousands of antibiotics in extinct organisms with AI by De la Fuente and his team.
June 11 (In Spanish) El País publishes an article on AI reviving mammoth molecules to create antibiotics.
June 11 (In Spanish) Antena 3 publishes an article about César de la Fuente leading a study that discovers almost one million new antibiotics in a few hours through AI.
June 11 Congratulations to Fangping, Marcelo, Jacqueline and Cesar on the publication “Deep-learning-enabled antibiotic discovery through molecular de-extinction” in Nature Biomedical Engineering.
June 10 Singularity Hub publishes a piece on the discovery of nearly a million potential antibiotics with AI to take out superbugs.
June 10 (In Spanish) Cambio 22 writes an article about the discovery of almos 1M potential antibiotics.
June 10 (In Spanish) El Correo del Sol writes an article about the discovery of nearly a million peptides in nature that could serve as antibiotics.
June 10 (In Spanish) La Jornada San Luis covers the discovery of almost 1M of new potential antibiotics.
June 10 (In Spanish) iSanidad writes an article on the development of antibiotics designed by artificial intelligence marking the beginning of a new era in infectious diseases.
June 10 (In Spanish) Prensa Latina writes an article on AI identifying nearly a million future antibiotics in nature.
June 10 (In Spanish) El Cronista covers the discovery of millions of new antibiotics hidden in nature.
June 8 (In Spanish) Crónica web writes an article about thousands of sources of new antibiotics to combat superbugs found using artificial intelligence.
June 8 (In Spanish) dpl News publishes a piece about researchers using AI to solve global problem of antibiotic resistance.
June 7 (In Spanish) Fuser News publishes an article on AI identifying nearly a million potential natural antibiotics.
June 7 (In Spanish) Cerebro Digital writes a piece about AI predicting the possibility of creating new antibiotics.
June 7 Penn Engineering Blog publishes an article on AI to accelerate antibiotic discovery.
June 7 Penn Engineering Today covers the largest-ever antibiotic discovery effort using AI to uncover potential cures in microbial dark matter.
June 6 (In Catalan) 3cat publishes an article on a new approach against antibiotic resistance.
June 6 WRPI covers the discovery of new potential antibiotics with AI.
June 6 (In Spanish) RTVE Galicia interviews César de la Fuente about his reserarch on AI antibiotic discovery.
June 6 Vozpópuli writes a piece about the discovery of new potential antibiotics to combat superbugs.
June 6 (In Spanish) RTVE Galicia interviews César de la Fuente about his reserarch on AI antibiotic discovery.
June 6 Mirage News publishes an article on the discovery of almost a million potential sources of antibiotics in the natural world.
June 6 Deutsche Welle publishes an article on the possibility that scientists are finally beating antimicrobial resistance.
June 6 (In Spanish) La Opinión A Coruña publishes an article on our discovery of nearly 1M potential antimicrobial molecules in global microbiome using AI.
June 6 (In Spanish) La Opinión A Coruña publishes an article on our discovery of nearly 1M potential antimicrobial molecules in global microbiome using AI.
June 6 GENENG NEWS covers our discovery of a treasure trove of antimicrobial Peptides using machine learning.
June 6 (In Spanish) EITB covers our discovery of almost 1M potential antimicrobials.
June 6 (In Spanish) MUNDIARIO publishes an article on the discovery of 860,000 new antibiotic molecules.
June 6 DNYUZ publishes an article on the use of AI to discover new antibiotics.
June 6 Lab Manager covers the largest-ever antibiotic discovery project to uncover potential cures.
June 6 Lab + Life Scientist publishes an article on the identification of over 800,000 antimicrobial peptides with machine learning.
June 5 Pledge Times writes a piece on the largest catalog of new antibiotic molecules revealed.
June 5  Health Medicine Network publishes an article on the finding of almost a million potential sources of next-gen antibiotics in the natural world.
June 5  The Microbiologist covers the largest-ever antibiotic dicovery effort using AI.
June 5 Bioengineer. org writes an article on unlocking the world around us to discover next-gen antibiotics.
June 5  Science Magazine publishes a pice on the largest-ever antibiotic discovery effort using AI to uncover potential cures in microbial dark matter.
June 5 Live Forever Club writes a piece about AI speeding up search for new potential antibiotic candidates.
June 5 (In Spanish) El Periódico publishes an article on the identification of nearly 1 M potential antibiotics.
June 5 SCIENCE DAILY publishes an article on the largest-ever antibiotic discovery effort uses AI to uncover potential cures in microbial dark matter.
June 5 (In Spanish) Diario de Pontevedra writes a piece on the participation of César de la Fuente in the discovery of nearly one million potential antimicrobials using AI.
June 5 (In Spanish) Diario de Tarragona publishes an article on the identification of nearly 1M unknown antimicrobial molecules.
June 5  (In Spanish) ARA publishes an article on the revolutionary leap in the search for new antibiotics.
June 5  (In Spanish) MSN publishes a piece on the identification of almost 1M potential antibiotics.
June 5 EUREKALERT publishes a piece on the unlocking of the world around us to discover next-gen antibiotics.
June 5 Penn Medicine publishes a piece on the largest-ever antibiotic discovery effort using AI to uncover potential cures in microbial dark matter.
June 5 MEDIUM publishes an article on the groundbreaking study using AI to predict potential new antibiotics.
June 5  (In Spanish) El Nuevo Diario publishes an article on the identification of nearly 1M potential antimicrobials.
June 5 SCIENCE DAILY covers the unlocking of the world around us to discover next-gen antibiotics.
June 5 (In Spanish) FORBES México publishes an article on the discovery of nearly 1M potential antibiotics using AI.
June 5 (In Spanish) La Voz de Galicia includes in the daily news podcast the discovery of almost 1M potential antibiotics.
June 5 (In Spanish) EUROPAPRESS GALICIA publishes an article on the participation of César de la Fuente in the discovery of nearly 1M potential antibiotics.
June 5 ZME Science publishes an article on the uncover of nearly one million potential antibiotics to fight drug-resistant superbugs.
June 5  (In Spanish) Diario de los Andes writes a piece on the identification of almost 1M potencial antibiotics.
June 5  (In Spanish) El Progreso publishes an article on the participation of César de la Fuente in the discovery of almost 1M antimicobial molecules.
June 5  (In Spanish) GALICIAPRESS writes an article on the participation of César de la Fuente in the discovery of almost 1M potential antimicrobials.
June 5  (In Spanish) Faro de Vigo publishes an article on our dicovery of potencial new antimicrobials in the global microbiome using AI.
June 5  (In Spanish) El Quincemil publishes an article on César de la Fuente’s participation in the discovery of new antibiotics using IA.
June 5  (In Spanish) La Ventana of Cadena Ser Radio covers our research published in Cell.
June 5  (In Spanish) NEWS ES EURO publishes a piece on our discovery of almost 1M potential antibiotics using AI.
June 5  (In Spanish) MEDICALXPRESS writes an article on our research finding almost a million potential sources of next-gen antibiotics in the natural world.
June 5 PHYS.ORG publishes a piece on our discovery of potential new antibiotics in the global microbiome using AI.
June 5  (In Spanish) yahoo! finanzas publishes an article on our discovery of almost 1 M potencial antibiotics.
June 5  (In Spanish) El imparcial publishes an article on our AI-driven discovery of almost 1 M potencial antimicrobials.
June 5 The Guardian covers our discovery of almost 1 M potential antibiotics and the creation of AMPSphere.
June 5 (In Spanish) El País publishes an article on AMPSphere.
June 5 Congratulations to the Machine Biology Group on the publication of the article “Discovery of antimicrobial peptides in the global microbiome with machine learning” in Cell.
June 5 César de la Fuente gives the opening keynote speech at the 8th International Symposium on Antimicrobial Peptides AMP 2024
June 2 (In Spanish) ASOMEGA publishes an article on César de la Fuente’s induction as ingresa Corresponding Academic at the Royal Academy Pharmacy of Galicia.
May 30 (In Spanish) César de la Fuente was the opening keynote speaker at the XXVII Congreso Nacional SEIMC at Zaragoza.
May 29 Listen here to the Naked Mole Rat podcast episode with César de la Fuente.
May 28 (In Spanish) Watch here Alex Fidalgo’s podcast with Cesar de la Fuente discussing our research.
May 26 (In Spanish) César de la Fuente interviewed by La Opinión A Coruña and El Correo Gallego.
May 25 (In Galician) Radio Galega talks about César de la Fuente and his work.
May 23 César de la Fuente is one of the co-authors of the editorial on the druggability, bio-safety, stability, and resistance of antimicrobial peptides published in Frontiers.
May 23 (In Spanish) Cadena Ser interviews Cesar de la Fuente on molecular de-extinction research for antibiotic discovery.
May 23 César de la Fuente gives a talk at the Faculty of Pharmacy of the University of Santiago de Compostela.
May 22 – (In Spanish) La Voz de Galicia publishes an article on César de la Fuente’s induction as member of the Royal Academy of Pharmacy of Galicia.
May 22 – (In Spanish) La Opinión de A Coruña publishes an article on César de la Fuente’s induction as member of the Royal Academy of Pharmacy of Galicia.
May 22 – César de la Fuente takes office as Corresponding Academic at the Royal Academy of Pharmacy of Galicia.
May 21 – New publication on Sciencedirect: Influence of antimicrobial peptides on the bacterial membrane curvature and vice versa.
May 20 – (In Spanish) Quincemil publishes an article on César de la Fuente’s induction as member of the Royal Academy of Pharmacy of Galicia.
May 15 – César de la Fuente has been invited to share our latest on AI for antibiotics at the Abu Dhabi Global Healthcare Week.
May 10 – César de la Fuente talks about AI for antibiotic discovery at CLIC2024.
May 8 – César de la Fuente takes part in the Global Young Academy’s 2024 International Conference of Young Scientists in Washington, D.C.
May 8 – (In Spanish) César de la Fuente talks to ABC about GoogleDeep Mind’s AlphaFold 3.
April 29César de la Fuente shares the latest work in AI for antibiotic discovery at Lisbon Medical Academic Center in Portugal.
April 24Listen here to the Penn Engineering Innovation and Impact Podcast with Cesar de la Fuente discussing our research .
April 21César de la Fuente delivers a seminar at 2024 ASIP annual meeting in Baltimore to talk about Artificial Intelligence for Antibiotic Discovey
April 17Check out in Nature one of the most personal interviews César de la Fuente have ever done: Five questions with César de la Fuente
April 16 – César de la Fuente participates on the National Academy of Medicine (NAM) Forum
April 12 – (In Spanish) ABC writes an article about the threats of unethical artificial intelligence and interviews César de la Fuente
April 7 (In Spanish) El Nuevo Día from Puerto Rico publishes an interview with César de la Fuente
April 3 Listen here to the podcast On Tech Ethics! episode with Cesar de la Fuente discussing our research and some related ethical considerations.
April 3 – César de la Fuente gives a talk on “AI for antibiotic discovery” and chat with future students at the Lower Merion High School’s Ace Scholars Seminar
April 2César de la Fuente gives a lecture on our latest AI antibiotics work at PennFERBS
March 30 – (In Spanish) César de la Fuente interviewed by El Quincemil
March 25 Congratulations to the Machine Biology Group on the publication of the article Peptides from non-immune proteins target infections through antimicrobial and immunomodulatory properties
March 20 New publication in Cell Reports Physical Science: Polyproline peptide targets Klebsiella pneumoniae polysaccharides to collapse biofilms
March 19 – (In Spanish) La Voz de Galicia publishes an article about Lucía Ageitos and her work
March 19 César de la Fuente has been named Alumni de Honor by the Universidad de León
March 18 – César de la Fuente and Angelica Cesaro share our latest work in AI for antibiotic discovery at New Antibacterial Discovery and Development Gordon Research Conference 
March 15 – (In Spanish) TecScience publishes an article about antibiotics and our AI work
March 14 – César de la Fuente shares our latest work in AI for antibiotic discovery at the 2024 IIZD Symposium
March 14 – (In Spanish) El Diario de León writes an article on César de la Fuente´s selection as the US representative of the Global Young Academy
March 12 – César de la Fuente delivers a seminar hosted by the Nanobioelectronics and Biosensors group at the ICREA
March 12 – (In Spanish) The Huffington Post publishes an article on César de la Fuente’s selection as the US representative at de Global Young Academy
March 11 – (In Spanish) El Quincemil publishes an article on the work developed by Lucía Ageitos at De La Fuente Lab
March 9 – César de la Fuente gives a keynote on “Future RX: Power of AI and the revolution of Medicine for Gen Z” in an event organized by the Ghana Medical Student Association
March 8 – The New York Times publishes an article about the scientific agreement to prevent AI Bioweapons, signed and supported by César de la Fuente
March 8 – César de la Fuente signs the statement for the Responsible Development of AI for Protein Design promoted by the Institute for Protein Design of the University of Washington
March 8Congratulations to the Machine Biology Group on the publication of the article Challenges in computational discovery of bioactive peptides in ’omics data in Proteomics.
March 6 – (In Spanish) César de la Fuente interviewed for the podcast “Historias para mentes curiosas”. TEDScience
February 26 – Our sustainable and low-cost diagnostic biosensors work was featured in The New York Times.
February 26 – (In Spanish) Quincemil publishes an article on César de la Fuente’s selection as member of the 2024 Class of Global Young Academy Inductees
February 26Congratulations to the Machine Biology Group on the publication of the article Synthetic angiotensin II peptide derivatives confer protection against cerebral and severe non-cerebral malaria in murine models in Nature.
February 20 – Our work has been mentioned in a The Inquirer piece on John Swartley
February 16 – Congratulations to César de la Fuente on his selection as member of the 2024 Class of Global Young Academy Inductees
February 13 – César de la Fuente interviewed for WebMD/Medscape article
February 10 New publication on Sciencedirect: AI in infectious diseases: The role of datasets
January 17 Cell Reports Physical Science  selected our paper “Structure-function-guided design of synthetic peptides with anti-infective activity derived from wasp venom” as a “Hot paper” of 2023
January 16 – Congratulations to César de la Fuente on his selection for the 2024 Journal of Nanobiotechnology Rising Star Award
January 9 – Congratulations to Marcelo Torres and César de la Fuente on the publication of Antibiofilm approaches as a new paradigm for treating infections
January 3 CNN Health interviews César de la Fuente about our latest AI work to discover new antibiotics to target antibiotic-resistant bacteria

2023

December 30 – (In Spanish) El Diario includes our molecular de-extinction research as some of the most exciting scientific finds of 2023
December 26 – Our work on molecular de-extinction is featured on the NY Post
December 26 CNN interviews Cesar de la Fuente for his expertise regarding “resurrection biology”
December 20 Scientific American  interviews Cesar on AI-discovered antibiotics
December 15 CNN publishes article on our molecular de-extinction research
December 1 – Congratulations to Cesar de la Fuente and Marcelo Torres on the publication of the article Recombinant production of antimicrobial peptides in plants
November 18 – (In Spanish)  Our research on molecular de-extinction is the topic of this episode of the Cadena SER Podcast
November 14 – (In Spanish) Listen here to a podcast Las Tarde episode with Cesar de la Fuente discussing our research.
November 7 University of Pennsylvania Almanac article on Cesar de la Fuente’s selection as a 2023 Emerging Leader in Health and Medicine (ELHM) Scholar by the National Academy of Medicine (NAM).
November 6 – (In Spanish) El Diario Spain interviews Cesar de la Fuente on molecular de-extinction research.
November 4 – (In Spanish) El Nacional publishes article about molecular de-extinction research
November 2 – Congratulations to Cesar de la Fuente and Angela Cesaro on the publication of the article Antibiotic failure: Beyond antimicrobial resistance
October 30 NPR interviews Cesar de la Fuente on the emerging field of molecular de-extinction.
October 29 – (In Spanish) Watch or listen to Radio el Respeto interview of Cesar de la Fuente, PI of the Machine Biology Group, conducted by renowned journalist Pablo Fuente.
October 25 STAT news interviews Cesar de la Fuente on molecular de-extinction research and the use of AI for antibiotic discovery.
October 19 – Congratulations to Marcelo, Yiming, and Cesar on the publication “Molecular hybridization strategy for tuning bioactive peptide function” in Nature Communications Biology.
October 19 – Cesar de la Fuente will be speaking at the Science Institute Museum and Library on AI for antibiotics discovery.
October 13 – (In Spanish) PI of the Machine Biology Group, Cesar de la Fuente was interviewed for the podcast Las 3 Principales, on the episode titled “La Ciencia de los Antibióticos”.
October 11 – Congratulations to Angelica and Cesar on the publication “Antibiotic identified by AI” in Nature Chemical Biology.
October 10 – (In Spanish) GCiencia publishes an article on our research on molecular de-extinction.
October 5 – Congratulations to the Machine Biology Group on the publication of the article “Deep learning tools to accelerate antibiotic discovery”.
September 26 Penn Medicine publishes a profile on Cesar de la Fuente and the lab’s research.
September 12 Nature Biotechnology and Penn Today publish articles on our molecular de-extinction research.
September 12 – (In Spanish) Radio Euskadi interviews Cesar on the lab’s latest research for their podcast.
September 7 The Daily Pennsylvania and Penn Today report on our research on low-cost and biodegradable COVID-19 tests.
August 28 – (In Spanish) GCiencia publishes an article on our research on a low-cost herpes diagnostic test.
August 25 – (In Spanish) Our paper on a “green” and low-cost COVID test using a bacterial cellulose substrate was covered by La Voz de Galicia.
August 24 – Our publication on molecular de-extinction of antibiotics has been featured in numerous press outlets including Chemistry World, Australian Geographic, Medical Xpress, and Smithsonian Magazine.
August 16 – Congratulations to Shuangzhe Lin and César de la Fuente on their article on “The emerging field of digital antibiotic discovery” on REVIVE GARDP. A special recognition for Lin for his great work on this article.
August 8 – Our latest work on molecular de-extinction was covered in a Preview for Cell Host & Microbe.
August 4 – (In Spanish) César de la Fuente was interviewed by the Aragón Radio podcast on the latest work from the team on molecular de-extinction.
August 3 – (In Spanish) Our molecular de-extinction paper was covered by numerous news outlets including Rosario3, La Razón, Nius Diario, y Xataka.
August 3 – Our latest research on molecular de-extinction of antibiotics was featured on NBC.
August 2 – (In Spanish) Our molecular de-extinction work was covered by History Latinoamérica.
August 1 The Science Times reports on our research on molecular de-extinction.
August 1 – Our work was covered by Sigal Samuel of Vox, who writes “Using AI, scientists bring Neanderthal antibiotics back from extinction”.
July 31 – Our research on molecular de-extinction was covered by The AI Breakdown in a 7-minute video.
July 31 – (In Spanish) Our molecular de-extinction work was covered by Newsweek.
July 31 – (In Spanish) Científicos estudian moléculas de nuestros antepasados para crear nuevos antibióticos – Yahoo.
July 31 – Online newspaper, Infobae, discusses our latest molecular de-extinction research.
July 31 – As reported on Phys.org: Bringing back extinct molecules to fight modern bacteria.
July 31 Technology Networks: “Using AI To Discover Neanderthal Antibiotics”.
July 31 – Cesar de la Fuente discusses his Science piece in Penn Today.
July 30 Chemical and Engineering News of the ACS covers our research on reprogramming wasp venom peptides into antibiotics.
July 29 – (In Spanish) La Opinión & Faro de Vigo hail our work as finding the ‘Jurassic Park’ of the pharmacy: antibiotics in Neanderthals.
July 28 – (In Spanish) Resucitan moléculas de neandertales para utilizarlas como antibióticos – La Voz Galicia.
July 28 – Machine Biology Group’s research on de-extinction of ancient antimicrobial peptides featured in Crisis Response Journal.
July 28 Nature reports on the Machine Biology Group’s newest publication: Molecular de-extinction of ancient antimicrobial peptides enabled by machine learning.
July 22 – (In Spanish) Related to our recent paper in Cell Reports Physical Science. Veneno de avispa como antibiótico para combatir potentes superbacterias – La Voz de Galicia.
July 20 GCiencia published an article on our new paper published in Cell Reports Physical Science.
July 20 Penn Engineering Blog covers a new piece published in Science and co-authored by Dr. de la Fuente.
July 13 – Congratulations to Cesar for his new article on the use of AI for infectious diseases published in Science.
July 11 – César de la Fuente Receives 2023 Rao Makineni Lectureship Award – Penn Engineering Blog.
May 26 – Antibióticos creados por ordenador ¿la solución a las resistencias bacterianas? CuidatePlus
May 26 – CNN interviews Cesar about a new paper published in Nature Chemical Biology by our colleagues at McMaster and MIT.
April 24 – Congrats Fangping and Cesar on your News and Views piece published in Nature Biomedical Engineering.
April 2 – Un gallego entra en la elitista academia que solo acoge al 2 % de los científicos del mundo – La Voz de Galicia.
February 23 – Our latest piece on Artificial intelligence accelerates efficient mining of functional peptides is out.
February 14 – Congratulations to Angelica and Lin for getting their review accepted in the journal Advanced Drug Delivery Reviews.
February 9 – The de la Fuente Lab work is covered in a new piece published by PNAS.
January 20 – Prof. de la Fuente is announced as an Associated Editor of the journal Digital Discovery.

2022

December 23 El Confidencial publishes an article about our upcoming publication.
December 2 – Prof. de la Fuente’s Awards and Accolades are highlighted by Penn Medicine News.
November – Our paper describing the first antibiotics discovered in ancient organisms is covered by the Spanish media.
November 15 – Our paper describing the first antibiotics discovered in ancient organisms is published in bioRxiv.
November 15 – Prof. de la Fuente is named a Highly Cited Researchers by Clarivate.
November 10 – The de la Fuente lab’s work mining the human proteome to identify novel antibiotics is covered by Diane Williams from DTRA.
October 26 – Prof. de la Fuente was invited by NIH to participate in a roundup post focused on antibiotic resistance.
September 21 – The National Institute of General Medical Sciences’ Biomedical Beat Blog published an interview with Cesar de la Fuente.
August 23 – A review by the de la Fuente Lab titled Molecular tools for probing the microbiome was published in Current Opinion in Structural Biology.
August 4 – Chemical Science published the paper titled An N-capping asparagine-lysine-proline (NKP) motif contributes to a hybrid flexible/stable multifunctional peptide scaffold that was led by Octavio Franco and David Craik’s groups and that the de la Fuente Lab contributed to.
July 18 – Biomaterials published Debulking different Corona (SARS-COV-2 delta, omicron, OC43) and influenza (H1N1, H3N2) virus strains by plant viral trap proteins in chewing gums to decrease infection and transmission, a project led by the Daniell Lab that the de la Fuente Lab contributed to.
June 16 – Medical News Today published an article titled Algorithm finds natural, unresistable antibiotic hiding in bacteria regarding the research outlined in this paper published in Science that includes an interview with Prof. de la Fuente regarding drug-resistant bacteria.
June 2 – Postdoctoral fellow Angelica Cesaro, Ph.D., received the Second Place CiPD Image Award at the 2022 Center for Innovation & Precision Dentistry (CIPD) Symposium for her poster on the ACS Nano paper of the same name, Synthetic Antibiotic Derived from Sequences Encrypted in Proteins from Human Plasma.
May 17 – The de la Fuente Lab is happy to be involved in a great collaborative work led by the Tishkoff Lab titled Impact of natural selection on global patterns of genetic variation and association with clinical phenotypes at genes involved in SARS-CoV-2 infection that was published in PNAS.
May 15 – A review article that Prof. de la Fuente contributed to entitled Probiotics: insights and new opportunities for Clostridioides difficile intervention was published in Critical Reviews in Microbiology.
May 12 – A new article by WIRED titled These Nanobots Can Swim Around a Wound and Kill Bacteria features the research with nanobots highlighted in the de la Fuente lab’s new paper in ACS Nano.
May 6 – Nature Biotechnology published a News & Views article titled Antibiotic Discovery with Machine Learning which was written by Cesar de la Fuente.
April 29 – The lab’s paper titled Autonomous Treatment of Bacterial Infections in Vivo Using Antimicrobial Micro- and Nanomotors was published in ACS Nano.
April 27 – Cesar de la Fuente was announced as an awardee of a 2022 Royal Spanish Society of Chemistry (RSEQ) Young Investigator Award.
March 31 – Digital Discovery published the review article titled Deep generative models for peptide design. It was written by de la Fuente Lab members Fangping Wan and Daphne Kontogiorgos-Heintz. Congratulations Fangping and Daphne!
March 31 – The lab’s paper The wasp venom antimicrobial peptide polybia-CP and its synthetic derivatives display antiplasmodial and anticancer properties is among Bioengineering & Translational Medicine’s top cited articles.
March 11 – ACS in Focus published Machine Learning for Drug Discovery, a book developed in the de la Fuente Lab that acts as a primer for students new to Machine Learning.
February 12 – El País published an interview with Cesar de la Fuente about his ongoing projects and scientific research within the Machine Biology Group.
February 7 – The de la Fuente Lab’s low-cost COVID-19 tests were featured in an article published by El País in Spanish and English.
February 4 – Voz de America published an article and video interview with Cesar de la Fuente about the low-cost COVID-19 antigen tests developed by the lab.
January 25 – RTVE Noticias interviewed Cesar de la Fuente for a video about the de la Fuente Lab’s development of COVID-19 tests.
January 21 – Our latest Nature BME paper will be featured on the January 2022 cover of Nature Biomedical Engineering.
January 20 – Our latest Nature BME paper is the fourth most-viewed article published in Nature Biomedical Engineering on a list of 25 articles ranked by unique pageviews.

2021

December 14 – Cesar de la Fuente appeared on the Forbes Top 50 Awarded Spaniards list.
November 30 – Economia 3 published an article about the de la Fuente Lab’s work on COVID-19 rapid tests.
November 30 – WIRED published an article An AI Finds Superbug-Killing Potential in Human Proteins about our latest Nature BME paper.
November 26 – A Behind The Paper article was posted on the Nature Bioengineering community page about our latest Nature BME paper.
November 24 – Cesar de la Fuente is on Clarivate’s 2021 annual list of Highly Cited Researchers, a list of the most highly cited scientists in the past decade with publications that are among the top one percent in the citation distribution in their fields.
November 16 – iSanidad’s article Un científico español descubre más de 2.600 antibióticos encriptados en proteínas del cuerpo humano covers our latest Nature BME paper.
November 15 – El Pais published an article about the research in our Nature BME paper as well as an article describing a variety of research on the human proteome by different groups including the de la Fuente Lab.
November 14 – ABC Galicia and el Correo Gallego published interviews with Cesar de la Fuente.
November 8 – NIUS published an interview with Cesar de la Fuente regarding our latest Nature BME paper.
November 8 – Penn Today published an article that covers our latest Nature BME paper.
November 8 – An article entitled Hallan docenas de nuevos antibioticos naturales dentro del cuerpo humano is published in Muy Interesante that covers our latest Nature BME paper.
November 8 – GEN spoke with Prof. de la Fuente regarding the lab’s work designing an algorithm to discover thousands of antimicrobial peptides in the human proteome that is detailed in our latest Nature BME paper.
November 6 – Faro de Vigo article Un cientifico gallego identifica unos 2.000 antibioticos ‘codificados’ en el organismo covers our newly published research from our latest Nature BME paper.
November 6 – La Opinion A Coruna publishes an article Una nueva via frente a las ‘superbacterias’ about the de la Fuente lab’s new publication in Nature BME.
November 4 – Penn Engineering Today posts the article Penn Researchers Show ‘Encrypted’ Peptides Could be Wellspring of Natural Antibiotics about the lab’s new publication in Nature BME.
November 4 – GCiencia and AAAS published information about the de la Fuente lab’s work discovering encrypted antibiotics in the human proteome that is featured in our latest Nature BME paper.
November 4 – The de la Fuente Lab’s new paper Mining for encrypted peptide antibiotics in the human proteome was published in Nature Biomedical Engineering.
October 15 – Newsy visited the de la Fuente Lab to discuss the path to FDA approval for our COVID-19 rapid tests.
September 29 – The lab’s paper “Antimicrobial Peptides: Potential Therapeutics Against Drug-Resistant Pulmonary Infections” is now published in Archivos de Bronconeumologia.
September 26 – An article on antibiotic resistance and artificial intelligence published on Medium refers to the de la Fuente Lab’s publication in Communications Biology on the same topic.
September 10 – Forbes Spain names Cesar one of their 100 Most Creative Spanish Individuals in the Business World.
September 9 – Communications Biology publishes the lab’s paper on “Accelerating antibiotic discovery through artificial intelligence”.
September 1 – Advanced Drug Delivery Reviews publishes the lab’s paper “Probiotic engineering strategies for the heterologous production of antimicrobial peptides”.
September 1 – Three University of Pennsylvania Ph.D. rotation students join the de la Fuente Lab: Patrick Exconde (BMB), Hannah Kim (BMB) and Jacqueline Peng (BE).
September 1 – Professor Katya Anaya from the Federal University of Rio Grande do Norte in Brazil joins the de la Fuente Lab through the Fulbright Scholar Program for a project on food preservation and safety.
August 31 – ACS Infectious Diseases publishes a paper on research surrounding a synthetic peptide derived from scorpion venom.
August 16 – Fangping Wan, Ph.D. joins the de la Fuente Lab as a postdoctoral fellow.
August 9 – Our faster and cheaper COVID-19 testing with pencil lead is featured in Penn Engineering Today.
August 4 – Cesar is announced as a member of the 2021-2022 ASM Distinguished Lecturer roster.
July 27 – The paper on the Low-cost Electrochemical Advanced Diagnostic (LEAD) COVID-19 test that was developed in the lab is now published in PNAS.
July 23 – Penn Health-Tech announces the 11 projects selected for the 2021-2022 cohort, including our “Low-cost diagnostic platform: For COVID-19 and other emerging pathogens”.
July 15 – Angelica Cesaro, Ph.D. joins the de la Fuente Lab as a postdoctoral fellow.
July 14 – Undergraduate lab member Daphne Kontogiorgos-Heintz is awarded Penn Bioengineering’s Blair Research Fellowship.
July 7 – Our paper “Low-cost biosensor for rapid detection of SARS-CoV-2 at the point of care” is published in Matter.
June 10 – ACS Infectious Diseases published the paper “Antimicrobial Susceptibility Testing of Antimicrobial Peptides Requires New and Standardized Testing Structures”.
April 1 – Daphne Kontogiorgos-Heintz is awarded the Penn Engineering Littlejohn Undergraduate Research Fellowship.
March 18 – Daphne Kontogiorgos-Heintz is awarded the Grant for Faculty Mentoring Undergraduate Research from the University of Pennsylvania Center for Undergraduate Research and Fellowships (CURF).
March 17 – The de la Fuente Lab’s paper “Molecular Dynamics for Antimicrobial Peptide Discovery” is now published in Infection and Immunity.
February 4 – A paper titled “Synthetic Biology and Computer-Based Frameworks for Antimicrobial Peptide Discovery” is published in ACS Nano.
January 13 – Great to start the year with a publication. Our new paper “Coatable and Resistance-Proof Ionic Liquid for Pathogen Eradication” is out in ACS Nano!
January 11 – Our COVID-19 rapid test begins clinical trials. Here an article which gives more details about our work from Penn Today.
January 5 – The lab’s work on rapid and low-cost COVID-19 diagnostics is featured by Penn Medicine.

2020

December 9 – Technical.ly published an article about the development of COVID-19 rapid tests by the de la Fuente Lab.
November 25 – Our new paper on “Light-emitting probes for labeling peptides” is published in Cell Reports Physical Science.
November 20 – Our paper was highlighted by the editors of Science in the Editors’ Choice section.
November – Cesar wins the AIChE’s 35 Under 35 Award.
October 30 – Cesar was selected as a chair of panel in the World Laureates Forum, Computational Biology Summit.
October 27 – Our paper “Repurposing a peptide toxin from wasp venom into antiinfectives with dual antimicrobial and immunomodulatory properties” describing the conversion of a wasp venom into novel antibiotics is covered by Penn MedicineEl Pais, and SciShow, among other media outlets.
October – Cesar is invited to an AIChE podcast to discuss his recent Langer Prize.
October – Cesar is awarded NIH MIRA Investigator.
October – Cesar wins the Brain & Behavior Research Foundation (BBRF) Young Investigator Award.
October 18 – Our new paper on “Strategies for antimicrobial peptide coatings on medical devices: a review and regulatory science perspective” is published in Critical Reviews in Biotechnology.
September 22 – Cesar was selected by the US National Academies to serve on the committee to “Exam long-term health and economic effects of antimicrobial resistance in the US”.
September 18 – We are proud to be a signatory (among > 10,000 others) of this important letter published in Science.
July 27 – Cesar is interviewed by the Spanish Press (La Opinion and La Voz de Galicia) on winning the inaugural NEMO Prize.
July 23 – The lab wins Inaugural Nemirovsky Engineering and medicine Opportunity (NEMO Prize) and was highlighted by the Penn Bioengineering Blog, the Penn Center for Innovation, and Medium.
July 12 – Our new paper on “Physical methods for controlling bacterial colonization on polymer surfaces” is out in Biotechnology Advances.
July 9 – Cesar published a review entitled “The value of antimicrobial peptides in the age of resistance” in the journal Lancet Infectious Diseases.
July 7 – We just published a review on Antimicrobial Susceptibility Testing of Antimicrobial Peptides to Better Predict Efficacy.
July 5 – Cesar is interviewed by the Philadelphia Inquirer on the impact of tighter visa restrictions on his research lab team.
June 5 – Cesar was interviewed by Nature Communications Biology.
June 4 – Cesar’s ACS Infectious Diseases Young Award and his selection to In Vivo’s “Rising Leaders” in the life sciences list are highlighted by Penn Medicine.
May 11-17 – Numerous media outlets, including La Voz de Galicia, GCienciaLa OpinionABC interviewed Cesar and covered the recent announcement of his ACS Infectious Diseases Young Investigators Award.
May 16 – Marcelo publishes a new paper in Bioengineering & Translational Medicine describing the previously undisclosed antiplasmodial and anticancer properties of venom from wasps.
May 8 – Lucia Ageitos and Cesar de la Fuente published an article in the Spanish newspaper La Opinion discussing the challenges of COVID-19 for science and our society as a whole.
May 7 – New paper published in Current Topics in Medicinal Chemistry: “Host defence cryptides from human apolipoproteins: applications in medicinal chemistry”.
May 5 – The lab was highlighted in the featured projects of the COVID-19 HPC Consortium.
May 4 – Cesar is selected as one of 30 Rising Leaders In The Life ScienceMore details.
April 25 – Cesar discussed in a Spanish newspaper the role of secondary bacterial infections in pandemics in general and COVID-19 in particular.
March 9 – Cesar spoke with Quanta Magazine about a new AI breakthrough and his related research.
March 5 – Cesar gave a talk at the Center for Cellular and Molecular Therapeutics (CCMT) Seminar Series at UPenn.
March 3 – Cesar’s Langer Prize was published in this week’s issue of the Almanac.
March 2 – Cesar was selected as Scialog Fellow by RCSA, the Paul G. Allen Frontiers Group and the Frederick Gardner Cottrell Foundation.
February 28 – Cesar gave a talk at the Penn Institute for Computational Science Colloquim Series at UPenn.
February 27 – Cesar spoke with Vox about a new AI breakthrough and his related research.
February 19 – Cesar gave a talk at the Inflammation Working Group Seminars at the Fox Chase Cancer Center, Philadelphia, PA.
February 13 – Cesar gave a talk at the Frontiers in Science Seminar Series UPenn Dental Medicine at UPenn.
February 8 – Cesar was featured in the Penn CAMB Newsletter.
January 8 – Cesar’s Langer Prize Fellowship was featured on the AlChE website.

2019

December 24 – The Machine Biology Group’s work was highlighted by the Dept. of BE at UPenn’s round-up of the year features stories.
December 16 – Cesar and Esther were featured in Penn Bioengineering Blog for their publication in Trends in Immunology.
December 2 – The Machine Biology Group was featured in Penn Today.
November 19 – Cesar was featured in newspaper Quincemil.
November 10 – Cesar was awarded the inaugural Langer Prize by the AlChE Foundation.
November 8 – Marcelo Torres was invited to give a talk at the World Anti-Microbial Resistance Congress USA 2019.
November 2 – Cesar gave a keynote lecture as a recipient of the Society of Hispanic Professional Engineers Young Investigators Award.
October 31 – Cesar gave a keynote lecture at the Society of Hispanic Professional Engineers Young Investigators Award.
October 29-30 – Cesar was invited to be the chair at the AlChE Annual Meeting – Microbes at Biomedical Interfaces Topical Conference in Orlando, FL.
October 25 – Cesar was invited to give a talk at the Penn Institute of Immunology RIP Seminar Series.
October 14 – Cesar was selected by the editors of the Journal of Molecular Biology as one of the most remarkable early career researchers able to inspire and shape the direction of their respective fields.
October 10 – Cesar was invited to give a talk at I International Microiota Conference in A Coruna.
September 30 – Cesar was invited to give a talk at the Penn Prokaryotic Seminar Series.
September 25 – Cesar gave a talk at the Microbiome Talk UPenn.
September 17 – Cesar gave his TR35 Innovations Under 35 talk at EmTech.
September 4 – Cesar was featured in The Daily Pennsylvanian.
September 3 – Cesar’s Penn Presidential Professorship highlighted by Penn Almanac.
August 23 – Cesar gave a talk at the CAMB-MVP Research Retreat in Swarthmore, PA.
August 14 – Official welcome from the Department of Bioengineering.
July 15 – Our paper In silico optimization of a guava antimicrobial peptide enables a combinatorial exploration for peptide design was named The Top 50: Chemistry and Materials Science papers from Nature Communications in 2018.
July 12 – Cesar is invited to give the commencement speech for la Caixa Fellowship cerimony in Barcelona, Spain.
July 11 – Cesar was named Penn Presidential Professor.
June 25 – Cesar was named to the TR35 for “Top Young Innovators Under 35” by MIT Technology Review.
June 24 – Cesar gave a talk at the UPenn Biochemistry and Biophysics Seminar (UPenn).
May 14 – Cesar gave a talk at the International Infection, Immunity and Inflammation Conference (I4C).
May 6 – Cesar was named GEN Top 10 Under 40.
May 3 – Cesar gave a talk at the Clinical Neurosciences Training Seminar (CNTS) Seminar Series, University of Pennsylvania, Philadelphia, PA, USA.
February 24  March 1 – Cesar is invited to speak at the 2019 Gordon Research Conference of Antimicrobial Peptides. Renaissance Tuscany Il Ciocco. Lucca (Barga), Italy.
February 22 – Cesar is invited to speak at ICTP-CSIC in Madrid, Spain.
February 7 – Cesar is invited to give an Amgen Seminar Series in Chemical Engineering at the University of Rhode Island. Providence, RI, USA.
January 22 – Cesar is invited to give a talk at the 8th Annual Symposium Synthetic Biology Center at MIT. Cambridge, MA, USA.
January 3 – Marcelo’s paper on Peptide Design Principles for Antimicrobial Applications is published in the Journal of Molecular Biology.

2018

December 7 – Marcelo’s paper where we convert a toxic wasp venom peptide into a viable antibiotic is published in Nature Communications Biology. A Behind the Paper piece was published accompanying the paper. This work was covered by numerous news outlets including MIT NewsBoston HeraldForbesDaily MailLa Voz de Galicia (in Spanish), La Opinión (in Spanish), El Correo Gallego (in Spanish) and others, and was a trending topic on Reddit.
December 7 – Cesar is invited to give a talk at the 6th Annual Meeting of the Boston Area Antibiotic Resistance Network. The Starr Center 185 Cambridge St, Boston, MA, USA.
November 16-17 – Cesar is invited to give the Keynote Address at the XLV Reunión Anual SOGAPAR. Ferrol, Galicia, Spain.
November 7-8 – Cesar is invited to give a talk at the Penn 5th Microbiome Symposium. University of Pennsylvania. Philadelphia, PA, USA.
October 29-30 – Cesar is invited to give a talk at the AIChE Annual Meeting – Microbes at Biomedical Interfaces Topical Conference, and is also invited to serve as AIChE Session CoChair. Pittsburgh, PA, USA.
October 18 – Cesar is invited to give a talk at the Microbial Systems Seminar Series at MIT. Cambridge, MA, USA.
October 11 – Cesar is invited to give a talk at the Penn Psychiatry Research Day. Philadelphia, PA, USA.
October 9 – Cesar is invited to give a talk at the MIT Biological Engineering Retreat in Boston, MA, USA.
May 30 – Cesar is invited to give the  Keynote Address, Annual Infectious Diseases Consortium (IDC) retreat at the Harvard Infectious Diseases Consortium. Harvard Medical School. Boston, MA, USA.
April – Cesar is invited to give a talk  at University of Pennsylvania.
March – Cesar is invited to give a talk at Cornell University.
March – Cesar is invited to give a talk at University of Colorado Boulder.
March – Cesar is invited to give a talk at Colorado State University.
March – Cesar is invited to give a talk at University of California, Berkeley.
February – Cesar is invited to give a talk at Carnegie Mellon University.
February – Cesar is invited to give a talk at Vanderbilt University.
February – Cesar is invited to give a talk at Boston University.
January – Cesar is invited to give a talk at Boston College.

2017

December – Our new review on Neuromicrobiology: how microbes influence the brain is out! The paper was selected to be featured in ACS Editors’ Choice.
December – Our collaboration with MIT colleagues is published in Advanced Materials: 3D printing of living responsive materials and devices.
Here is the MIT News coverage!
November – Our work was featured in Popular Science!
November – Our work was featured in MIT News!
November – Cesar has been selected as a top Spanish innovator.
November – Cesar was featured in a Spanish documentary about antibiotic resistance. Here are the trailerand a section of the documentary.
November – Cesar is Interviewed by Dr. Stephen Hoare and Dr. Sophie Rose during the 8th International Meeting on Antimicrobial Peptides (IMAP 2017) in Copenhagen in August 2017.
November – Cesar is invited to attend the 2017 Boston Latino 30 Under 30 ceremony.
October – Cesar attends the Boston Area Antibiotic Resistance Network Annual Meeting 2017 at the American Academy of Arts and Sciences.
October – Our new paper on constrained antimalarial agents derived from the peptide hormone angiotensin II is published in Scientific Reports.
September – Cesar gives a talk at the Broad Institute of MIT and Harvard, Cambridge, MA, USA.
August – Our new paper describing a computational-experimental platform for the discovery of novel peptide antibiotics in complex biological information is published in ACS Synthetic Biology.
Here is MIT News coverage.
August – Cesar is invited to give a talk at the 7th International Meeting on Antimicrobial Peptides in Copenhagen, Denmark.
Coverage by MIT News and by La Voz de Galicia.
July – Cesar is invited to participate as Discussion Leader in the “Synthetic Biology” Gordon Research Seminar (GRS).  Stoweflake Conference Center, Stowe, VT, USA.
July – Cesar participates in the 5th annual workshop on “Micro- and Nanotechnologies for Medicine: Emerging Frontiers and Applications”, organized by the Biomaterials Innovation Research Center, Wyss Institute for Biologically Inspired Engineering, and Brigham and Women’s Hospital.
July – Our paper describing CO2-reactive ionic liquid surfactants that can reversibly bind to DNA upon bubbling with CO2 and N2 is published in Langmuir.
July – Cesar is invited to give a talk at the University of Connecticut. Storrs, CT, USA.
June – Our new paper on antibiofilm ciprofloxacin-nitroxide hybrids is out in the European Journal of Medicinal Chemistry.
June – Our new review on precision antimicrobials is out in Current Opinion in Microbiology. Great collaboration with Francis Mojica, co-discoverer of CRISPR.
June – Cesar completes the MIT Kaufman Teaching Certificate Program (KTCP)!
May – Cesar is invited to serve in the committee for Alex Guevara’s Master’s thesis defense at the Universidad Nacional de Colombia.
May – Cesar is invited to give a talk at the 13th Annual Protein Engineering Summit. Boston, MA, USA.
April – Our latest work describing a genetic algorithm-based computational approach for “evolving” naturally occurring peptides into “artificial” antibiotic candidates is published in Nature Communications.
April – Cesar is invited to give a talk at Massachusetts General Hospital. Charlestown, MA, USA.
April – Cesar is invited to give an Invited Seminar at Penn State University, PA, USA.
March – Cesar is selected as an ACS Nano Fellow and is invited to the first ACS Nano Kavli Futures Symposium. ACS Nano Kavli Futures Symposium. University of California-Los Angeles, CA, USA.
March – Cesar is invited to give an Invited Seminar at the California Institute of Technology. Pasadena, CA, USA.
January – Our paper describing a novel yeast-based synthetic biology platform for antimicrobial peptide production is published in ACS Synthetic Biology!
January – Our paper on versatile and on-demand biologics co-production in yeast is published in Nature Communications.

2016

December – Cesar gives a talk at Antibacterial Discovery and Development Summit. Boston, MA, USA
October – Cesar was invited to attend EmTech at MIT Media Lab!
October – Cesar was selected as MIT Technology Review Innovators Under 35. Madrid, Spain. Read Article
July – Cesar gives a talk at Institute for Bioengineering of Catalonia. Barcelona, Spain.
June – Cesar presents at the International Biochemistry and Molecular Biology meeting. Natal, Rio Grande do Norte, Brazil.
June – Cesar gives a talk at University of Campo Grande, Mato Grosso do Sul, Brazil.
May – Cesar gives a talk at Harvard Medical School, Boston, MA, USA.
March – Cesar gives a talk at Harvard University, Cambridge, MA, USA.
February – Cesar participates as a panelist in ECUSA CRISPR Symposium.
January – Cesar gives a talk at the Synthetic Biology Center. MIT, Cambridge, MA, USA.

2015

December – Cesar presents at the Spanish National Biotechnology Centre, CSIC. Madrid, Spain.
July – Cesar presents at the Synthetic Biology Group. MIT. Cambridge, MA, USA.
June – Cesar gives a talk at the University of British Columbia, Vancouver, BC, Canada.
June – Cesar gives a talk at University of Santiago de Compostela, Spain.
March – Cesar gives a talk at University of A Coruña, University Hospital, Spain.

2014

December – Cesar presents at the Young Investigators Seminar. Barrié Foundation and University of A Coruña, Spain.
September – Cesar presents at the University of British Columbia, Vancouver, BC, Canada.